Defective expression of basement membrane-associated C3d,g in papulonodular basal cell carcinomas  by Basset-Séguin, Nicole et al.
- 
Defective Expression of Basement Membrane- 
Associated C3d,g in Papulonodular Basal Cell 
Carcinomas 
Nicole Basset-SCguin, M.D., Paul Uhle, M.D., Diane Emanuel, B.S., Paula Henry, M.A., and 
Kim B. Yancey, M.D. 
Department of Dermatology, Uniformed Services University of the Health Sciences, Bethesda, Maryland (NB-S, PH, KBY); 
Department of Dermatology, Hospital Saint-Charles, Montpellier, France (NB-S); Department of Dermatology, Naval Medical 
Center, National Capitol Region, Bethesda, Maryland (PU); and School cf Medicine, Georgetown University, Washington, D.C., 
U.S.A. (DE) 
Recent studies in our laboratory have shown that C3d,g, a 
41 ,OOO-Da fragment of the third component of complement, 
is present along the base of the lamina densa and in the 
sublamina densa region of normal human e 
P 
idermal base- 
ment membrane, but absent from the skin o a atient with 
congenital C3 deficiency. In studies of human s f: in, papulo- 
nodular basal cell carcinomas have served as a useful model 
for the investigation of various basement membrane antigens 
and matrix proteins. To further investigate the presence of 
CSd,g within epidermal basement membrane as well as ex- 
amine its relationship with other known basement mem- 
brane constituents, we have analyzed serial sections of ten 
papulonodular basal cell carcinomas by light and immuno- 
fluorescence microscopy. In these studies, C3d,g was either 
absent (N = 9) or minimumly detectable (N = 1) in tumor 
nest basement membranes. While bullous pemphigoid and 
KF-1 antigens were absent (N = 6 and N = 3, respectively) 
or significantly decreased (N = 4 and N = 7, respectively), 
epidermolysis bullosa acquisita antigen was routinely present 
though somewhat (N = 3) or moderately decreased (N = 3). 
Laminin and type IV collagen were expressed normally in all 
tumor nest basement membranes. All constituents, including 
CSd,g, were 
membrane o P 
resent in adjacent normal epidermal basement 
these tumor samples. This study has demon- 
strated antigenic alterations within each ultrastructural sub- 
region of papulonodular basal cell carcinoma tumor nest 
basement membranes by identifying the virtual absence of 
C3d,g (sublamina densa) as well as a significant reduction in 
KF-1 (lamina densa) and bullous pem 
antigens. Moreover, the 
higoid (lamina lucida) 
gen, and epidermolysis 1 
resence of aminin, type IV colla- P 
ullosa acquisita antigen in tumor 
nest basement membranes suggests that these particular con- 
stituents neither cleave C3 nor act as essential binding sites 
for passive incorporation of this complement component in 
epidermal basement membrane. These studies give addi- 
tional support to the hypothesis that C3d,g is a previously 
unrecognized constituent of normal epidermal basement 
membrane and does not represent passive incorporation of 
circulating C3 at this site in human skin. J Invest Dermatol 
92:734 - 738, 1989 
R ecent studies in our laboratory have shown that C3d,g, a 41,000-Da cleavage fragment of the third component of complement, is present in normal human epidermal basement membrane (BM) [l]. ,Moreover, the demonstration that C3d,g is absent 
from the epidermal basement membrane of a patient with congeni- 
tal C3 deficiency has confirmed the specificity of this observation 
and dismissed the possibility that it represents the presence of a 
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cross-reacting antigen or C3 analogue. In these studies of normal 
human skin, C3d,g has been found to be confined to the epidermal 
BM where it is found along the base of the lamina densa and within 
the sublamina densa region by immunoelectron microscopy. C3d,g 
has not been found within dermal microvascular basement mem- 
branes although recent studies have identified its 
P 
resence in renal, 
tracheal, and placental basement membranes [1,2 . 
In studies of human epidermal basement membrane, pa 
ular basal cell carcinomas (PNBCCS) have served as a use P 
ulonod- 
ul model 
for the investigation of various BM antigens and matrix proteins. 
These studies have demonstrated defective expression of selected 
antigens in BM surrounding PNBCC tumor nests such as the ab- 
sence or substantial reduction of bullous pemphigoid (BP) antigen 
as well as the decreased expression of anchoring fibril markers AF, 
and AF, [3 - 61. In contrast, laminin and type IV collagen have been 
shown to be present in a normal amount and distribution within 
BMs of these tumor nests [4,7 - 91. The consistency and specificity 
of these alterations supports the concept that these tumors are a 
useful substrate for the study of human epidermal BM. In this study, 
PNBCC have been used to extend our understanding of epidermal 
BM C3d,g. In addition, the distribution and intensity of C3d,g 
within PNBCC tumor nest BM have been compared with known 
antigens and matrix proteins to evaluate possible relationships be- 
tween these constituents. 
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MATERIALS AND METHODS 
Tissue Samples Tissue samples from ten histologically confirmed 
PNBCC were provided by Dr. Parlette (Naval Hospital Bethesda, 
Bethesda, MD). Samples of normal adult human skin were provided 
by Dr. Katz (National Cancer Institute, National Institutes of 
Health, Bethesda, MD). Following excision, tissue samples were 
immediately placed in O.C.T. Compound (Lab-Tek Products, Na- 
perville, IL), frozen, and stored at -30 to -70°C. 
Reagents Rabbit anti-human C3d (Dako Corporation, Glostrup, 
Denmark) reacts with C3d,g as well as with its subsequent degrada- 
tion product, C3d. This antibody was used to identify these C3 
cleavage fragments, which are hereafter referred to as C3d,g. Pre- 
vious studies [l] with specific monoclonal antibodies confirmed the 
presence of both C3d and C3g within normal epidermal BM and 
were not repeated here. Rabbit anti-type IV collagen and rabbit 
anti-mouse laminin were acquired from Collaborative Research, In- 
corporated (Bedford, MA). Sheep anti-type IV collagen was pro- 
vided by Dr. Stanley (National Cancer Institute, National Institutes 
of Health, Bethesda, MD). KF-1, a murine monoclonal antibody 
that recognizes a noncollagenous component of the lamina densa of 
normal human epidermal BM [lo], was provided by Dr. Katz. Fluo- 
rescein isothiocyanate (FITC) conjugated rabbit anti-sheep IgG 
(Tago Incorporated, Burlingame, CA), FITC-conjugated goat anti- 
mouse IgG (Tago), FITC-conjugated goat anti-human IgG (Cap- 
pel, Malvern, PA), and samples of normal rabbit, sheep, and mouse 
sera (Gibco, Grand Island, NY) were used as second-step and con- 
trol reagents as previously described [l]. Serum samples from pa- 
tients with documented BP or epidermolysis bullosa acquisita 
(EBA) contained IgG anti-epidermal BM antibodies at titers of 
1: 320 and 1: 160, respectively. These sera were used as standard 
reagents to determine expression of these epidermal BM antigens in 
samples of normal human skin and PNBCC. 
Immunofluorescence and Light Microscopy Studies Six-mi- 
cron frozen sections of tissue were placed on albumin-coated slides 
and used for immunofluorescence microscopy studies. With tumor 
samples, every sixth tissue section was placed on an untreated glass 
slide, fixed in ethanol, stained with hematoxylin/eosin, and studied 
by light microscopy for reference purposes. Immunofluorescence 
microscopy was performed with the various reagents and controls as 
previously described [l]. All samples were tested in duplicate and 
independently evaluated as unknowns by at least two investigators. 
Immunofluorescence microscopy slides were viewed with a Leitz 
Ortholux II microscope equipped with a camera (Wetzler, Ger- 
many). In all PNBCC tissue sections, overlying and adjacent epi- 
dermal BM as well as BM surrounding dermal tumor nests were 
studied for the expression of BP, EBA, and KF-1 antigens as well as 
type IV collagen, laminin, and C3d,g. 
RESULTS 
Immunofluorescence and Light Microscopy Studies In con- 
trol studies on sections of normal adult human skin, rabbit anti- 
human C3d bound to the epidermal BM in a continuous, somewhat 
stitched, linear pattern. Similar staining was observed in adnexal 
BM; however, as previously described, rabbit anti-human C3d did 
not bind dermal microvascular BM [l]. In PNBCC tumor nest BM, 
C3d,g was either completely absent (N = 9) or minimally detect- 
able (N = 1) (Fig 1). Multiple tumor nest BMs within these lesions 
were consistently negative for C3d,g. Although one specimen did 
show evidence of C3d,g within some tumor nest BMs, its staining 
intensity was very faint. While epidermal BM directly overlying 
tumor nests showed reduced expression of C3d,g in four of ten 
BCC specimens, this C3 cleavage fragment was found in this loca- 
tion in all samples at sites adjacent to tumor (Fig 2 and Table I). 
Comparative studies with antibodies directed against other known 
BM antigens and matrix proteins were conducted in parallel on 
these tumor samples (Fig 3 and Table I). In brief, BP antigen was 
absent (N = 6) or notably decreased (N = 4) in BM surrounding 
PNBCC tumor nests. The epidermal BM overlying tumor nests was 
Figure 1. Immunofluorescence microscopy of epidermal and PNBCC 
tumor nest BMs after incubation with rabbit anti-human C3d (1: 20). Con- 
tinuous staining is present in the epidermal BM while PNBCC tumor nests 
(T) are negative. 
consistently positive for BP antigen, although the staining intensity 
of this glycoprotein was quite reduced in two samples. KF-1 antigen 
was absent (N = 3) or significantly decreased (N = 7) in BM sur- 
rounding PNBCC tumor nests, but present in the overlying epider- 
ma1 BM of all specimens. Laminin and type IV collagen were 
present in a bright, linear pattern in BMs of PNBCC tumor nests, 
the overlying and adjacent epidermis, and the microvasculature of 
all samples studied. While the EBA antigen was consistently present 
in epidermal and tumor nest BMs of all PNBCC specimens, its 
staining intensity in the latter location was either somewhat 
(N = 3) or moderately decreased (N = 3). In PNBCC tumor nest 
BMs, which showed some degree of staining for C3d,g, KF-1, or 
BP antigen, there was significantly less staining of deep tumor lob- 
ules than of superficial ones. 
In this study, 
diminished in 
C3d,g has been shown to be absent or substantially 
BM surrounding tumor nests of PNBCC. This find- 
DISCUSSION 
ing, as well as the reduction in expression of KF-1 in these lesions, 
represents previously undescribed defects within PNBCC tumor 
nest BM. In addition, these studies confirm that BP antigen is nota- 
bly diminished within PNBCC tumor nest BM, while laminin, 
type IV collagen, and EBA antigen are present in substantial quan- 
tity. These findings demonstrate a more extensive series of defects 
within BM of these lesions than has previously been recognized. 
Specifically, alterations within each ultrastructural subregion of 
PNBCC tumor nest BM have been documented (i.e., BP antigen 
within the lamina lucida, KF-1 antigen in the lamina densa, and 
C3d,g along the base of the lamina densa and within the sublamina 
densa region). Although of varying degree, these alterations have 
been consistent. 
The basis for these documented abnormalities within BMs of 
PNBCC tumor nests is not known. One possible hy 
B 
othesis is that 
certain epidermal BM constituents are not produce by neoplastic 
keratinocytes within these tumors. Previous studies have demon- 
strated that laminin, type IV collagen, BP antigen, and EBA antigen 
are produced by keratinocytes [ll - 191. Although the exact origin 
of C3d,g within epidermal BM is not known, the possibility exists 
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Figure 2. Immunofluorescence (A) and light microscopy (B) ofsequential frozen sections of a PNBCC. C3d,g within epidermal BM overlying this PNBCC 
tumor nest is brightest on the right side ofthefield; the epidermal BM on the Iefrsideofihefieldexemplifies the diminished expression of C3d,g which was observed 
overlying tumor nests in some PNBCCs. The PNBCC tumor nest BM shows no evidence of C3d,g. 
that it too may originate from keratinocytes, because recent studies 
have shown that A431 cells [2,20], a human cutaneous squamous 
carcinoma cell line, as well as normal human keratinocytes [20], 
synthesize and secrete C3 in vitro. If keratinocyte-derived C3 is a 
marker of cell differentiation (as has been postulated for BP antigen 
[4]), it may understandably be absent or deficient within PNBCC or 
overlying, possibly tumor-associated epidermal BM. Conversely, 
these BM constituents may be produced normally within these 
tumors then destroyed or altered by proteases aberrantly produced 
within or induced by PNBCC [21-231. Such protease activity 
could also account for the reduced expression of C3d,g in epidermal 
BM overlying PNBCC tumor nests of selected samples in this 
study. 
In this study, BMs of PNBCC tumor nests have also served as a 
useful substrate to investigate the relationship between C3d,g and 
other known BM antigens and matrix proteins in vivo. In this re- 
gard, C3d,g was absent from PNBCC tumor nest BMs des ite the 
presence of laminin, type IV collagen, and EBA antigen. T K is lack 
of association suggests that the absence of C3d,g at these sites is not 
directly related to a corresponding deficiency of one of these BM 
constituents. Moreover, these constituents must not serve as essen- 
tial binding sites for passive incorporation of C3 or C3d,g within 
epidermal BM. Interestingly, a recent study has demonstrated that 
C3 (as well as hydrolyzed C3) b’ d 1 m s aminin in vitro, and that this 
interaction may account for the presence of C3 (in the form of C3d) 
within renal and placental BMs [2]. Our studies of human skin 
suggest an alternate hypothesis because C3d,g is localized to a dif- 
ferent ultrastructural subregion of the epidermal BM as well as 
absent from laminin-rich PNBCC tumor nest and dermal microvas- 




Table I. Basement Membrane Antigens in Papulonodular Basal Cell Carcinomas’ 
Type IV KF-1 EBA 
Laminin Collagen Antigen Antigen C3d,g 
No. EBMb TBM= EBM TBM EBM TBM EBM TBM EBM TBM EBM TBM 
- 
1 +++ + +++ +++ +++ +++ ++ + +++ +-l- + - 
2 ++ - +++ +++ +++ +++ ++ -e +++ ++ f 
3 ++ - +++ +++ +++ +++ ++ f +++ + ++ - 
4 +i- _ +++ +++ +++ +++ ++ - +++ + + - 
5 + + +++ +++ +++ +++ U -t +++ +++ + - 
6 ++ * +++ +++ +++ +++ ++ -t ++t +++ + - 
7 ++ - u+ +++ +++ u+ U 5 +++ + + -t 
8 +++ - +++ u+ u+ +++ +++ - +u +++ f - 
9 +++ Ik +++ +++ +++ +++ + - +u ++ xk - 
10 + - u+ +++ +++ u+ +++ + +++ +++ f - 
= Results of immunofluoresccnce microscopy arc presented as follows: f: faint; +: positive; ++z bright pattern of staining; and +++: very bright pattern of staining. 
b EBM: epidermal basement membrane overlying PNBCC tumcn nests. 
c TBM: PNBCC tumor nest basement membranes. 
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Figure 3. Light (A,C) and immunofluorescence (B,D,E, and F) microscopy of frozen sections of a PNBCC. Staining of a sequential section of the PNBCC 
shown in panel A with antibodies directed against laminin demonstrates the presence of this BM constituent within epidermal, microvascular, and tumor nest 
BMs (B). Similarly, ehe PNBCC shown in C demonstrates BP antigen (0) and type IV collagen (E) within tumor nest BM which was negative for KF-1 (F). 
As shown above, the epidermal BMs of the PNBCC shown inpanel C was positive for each of these constituents; type IV collagen was also demonstrated in 
dermal microvascular BM of this specimen (E). 
and EBA antigen within PNBCC tumor nest BMs suggests that 
these matrix proteins do not produce low grade, continuous activa- 
tion of circulating C3, which results in subsequent incorporation of 
C3d,g within epidermal BM. Although some degree of co-associa- 
tion exists in the defective expression of C3d,g, KF-1, and BP anti- 
gens in PNBCC tumor nest BMs, these constituents are located 
within different ultrastructural subregions of the epidermal BM. 
Hence, it is unlikely that these constituents act as essential binding 
or activation sites for C3 in epidermal BM. 
In summary, this study has utilized PNBCC as a model substrate 
to extend our understanding of C3d,g within human epidermal BM 
and further define its relationship with other known components of 
this important ultrastructural region. These findings add further 
support to the hypothesis that C3d,g is a previously unrecognized 
component of normal epidermal BM and does not represent passive 
incorporation and local degradation of circulating C3 at this site in 
human skin. 
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